Growth Hormone Peptides: Sermorelin, Ipamorelin, and the Case Against HGH

Synthetic human growth hormone (HGH) replaces what your pituitary makes — often at doses that push levels well above physiologic norms. The results can look dramatic in the short term, but the trade-offs (insulin resistance, fluid retention, joint pain, cost, and legal restrictions) are significant.

Growth hormone-releasing peptides like sermorelin, ipamorelin, and CJC-1295 take a different approach. They stimulate your own pituitary to release growth hormone in its natural pulsatile pattern, preserving the feedback loops that keep the system safe.

Realistic expectations matter. Most patients notice deeper sleep within two to four weeks, then gradual improvements in recovery, body composition, and skin quality over three to six months. Anyone promising overnight transformation is selling something.

We screen for contraindications — active cancer, uncontrolled diabetes, severe sleep apnea — and check IGF-1 at baseline and during therapy to ensure levels stay in a safe, age-appropriate range.

For the right patient, growth hormone peptides are a meaningful longevity tool. For the wrong patient, they're an expensive distraction from sleep, training, and nutrition.